Acquisition by Dolatrai Vyas of 20000 shares of Spectrum Pharmaceuticals subject to Rule 16b-3
| SPPIDelisted Stock | USD 1.03 0.00 0.00% |
Under 56% of Spectrum Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Spectrum Pharmaceuticals suggests that many traders are alarmed regarding Spectrum Pharmaceuticals' prospects. Spectrum Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Spectrum Pharmaceuticals. The current market sentiment, together with Spectrum Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Spectrum Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Spectrum Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Spectrum daily returns and investor perception about the current price of Spectrum Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Spectrum |
Filed transaction by Spectrum Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Spectrum Pharmaceuticals Fundamental Analysis
We analyze Spectrum Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spectrum Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spectrum Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Spectrum Pharmaceuticals is currently under evaluation in working capital category among related companies. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Spectrum Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spectrum Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Spectrum Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Spectrum Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Spectrum Pharmaceuticals Related Equities
| MCRB | Seres Therapeutics | 8.79 | ||||
| HEPA | Hepion Pharmaceuticals | 6.20 | ||||
| BLRX | BioLineRx | 4.69 | ||||
| VSTM | Verastem | 3.63 | ||||
| IMMP | Immutep | 0.75 | ||||
| AGIO | Agios Pharm | 0.79 | ||||
| ARDX | Ardelyx | 0.93 | ||||
| LXRX | Lexicon Pharmaceuticals | 1.28 | ||||
| AVRO | AVROBIO | 1.65 | ||||
| RIGL | Rigel Pharmaceuticals | 1.87 | ||||
| CRVS | Corvus Pharmaceuticals | 1.90 | ||||
| BLUE | Bluebird Bio | 3.26 | ||||
| GERN | Geron | 5.07 | ||||
| KPTI | Karyopharm Therapeutics | 6.36 | ||||
| ZURA | Zura Bio | 7.97 | ||||
| IBRX | Immunitybio | 11.12 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |